02983nas a2200385 4500000000100000008004100001260000900042653001500051653001000066653000900076653002800085653001100113653002900124653001400153653001100167653002400178653001200202653000900214653001600223653001000239653001600249100001300265700001200278700001300290700001300303700001200316700001600328245010900344856007700453300001000530490000600540050001500546520202200561022001402583 2013 d c201310aAdolescent10aAdult10aAged10aDelivery of Health Care10aFemale10aHealth Services Research10aHospitals10aHumans10aInterviews as Topic10aleprosy10aMale10aMiddle Aged10aNepal10aYoung Adult1 aRaffe SF1 aThapa M1 aKhadge S1 aTamang K1 aHagge D1 aLockwood DN00aDiagnosis and treatment of leprosy reactions in integrated services--the patients' perspective in Nepal. uhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591330/pdf/pntd.0002089.pdf ae20890 v7 aRAFFE 20133 a

UNLABELLED: Leprosy care has been integrated with peripheral health services, away from vertical programmes. This includes the diagnosis and management of leprosy reactions, which cause significant morbidity. We surveyed patients with leprosy reactions at two leprosy hospitals in Nepal to assess their experience of leprosy reaction management following integration to identify any gaps in service delivery.

METHODS: Direct and referral patients with leprosy reactions were interviewed in two of Nepal's leprosy hospitals. We also collected quantitative and qualitative data from clinical examination and case-note review to document the patient pathway.

RESULTS: Seventy-five patients were interviewed. On development of reaction symptoms 39% presented directly to specialist services, 23% to a private doctor, 17% to a district hospital, 10% to a traditional healer, 7% to a health post and 4% elsewhere. Those who presented directly to specialist services were 6.6 times more likely to start appropriate treatment than those presenting elsewhere (95% CI: 3.01 to 14.45). The average delay between symptom onset to commencing corticosteroids was 2.9 months (range 0-24 months). Obstacles to early presentation and treatment included diagnostic challenge, patients' lack of knowledge and the patients' view of health as a low priority. 40% received corticosteroids for longer than 12 weeks and 72% required an inpatient stay. Treatment follow-up was conducted at locations ranging from health posts to specialist hospitals. Inconsistency in the availability of corticosteroids peripherally was identified and 41% of patients treated for leprosy and a reaction on an outpatient basis attended multiple sites for follow-up treatment.

CONCLUSION: This study demonstrates that specialist services are necessary and continue to provide significant critical support within an integrated health system approach towards the diagnosis and management of leprosy reactions.

 a1935-2735